Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)

Sponsor
Pennington Biomedical Research Center (Other)
Overall Status
Completed
CT.gov ID
NCT01872533
Collaborator
(none)
9
1
1
22
0.4

Study Details

Study Description

Brief Summary

The purpose of this study is to look at how a reduction in oxygen levels (hypoxia) influences insulin sensitivity and carbohydrate metabolism. It is expected that 10 nights of exposure to moderate hypoxia (~ 15% O2, similar to conditions at an altitude of ~7500 feet) will improve glucose metabolism.

Condition or Disease Intervention/Treatment Phase
  • Other: Hypoxia Exposure
Early Phase 1

Study Design

Study Type:
Interventional
Actual Enrollment :
9 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)
Study Start Date :
Jul 1, 2011
Actual Primary Completion Date :
Sep 1, 2012
Actual Study Completion Date :
May 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Hypoxia Exposure

There was only one study arm: All participants slept in moderate hypoxia (see description below).

Other: Hypoxia Exposure
Participants spent 10 consecutive nights (approximately 100 hours of exposure) in a hypoxic tent at ~ 15% O2 (ca. 2400 m elevation).

Outcome Measures

Primary Outcome Measures

  1. Change in Insulin sensitivity [Change from baseline to 10 nights of hypoxia exposure]

    Glucose disposal and oxidation were measured using a two-step hyperinsulinemic euglycemic clamp and indirect calorimetry.

Secondary Outcome Measures

  1. Change in oxygen tension in adipose tissue [Before and after 10 nights of hypoxia exposure]

    pO2 levels were measured in adipose tissue both under hypoxia and normal oxygen conditions (normoxia) via a dual temperature-oxygen tension probe.

  2. Glucose uptake in myotubes [Before 10 nights of hypoxia exposure]

    Glucose uptake assays were performed in the presence or absence of hypoxia on myotubes harvested from muscle biopsies.

  3. Change in gene and protein expression [Before and after 10 nights of hypoxia exposure]

    Gene and protein expression of some hypoxia-responsive and insulin-signaling markers were measured in biopsied muscle and adipose tissue via RT-PCR and Western blotting, respectively.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 45 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Aged 20-45 years

  • Male

  • Obese category (BMI > 30 kg/m2)

  • Healthy as assessed by a self-reported health questionnaire

  • Non-smokers

  • Weight stable over the past 3 months (<2kg fluctuation)

Exclusion Criteria:
  • Female

  • Diabetes

  • Sleep apnea

  • Hypertension

  • History of altitude sickness

  • Individuals taking any chronic medications

  • Individuals taking any stimulants

  • Individuals taking beta-blockers

  • Individuals with chronic alcohol consumption (>3 drinks per day) or drug abuse.

  • Individuals unable to abstain from caffeinated beverage or alcohol the days of study testing

  • Individuals with history disease or history of stroke

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pennington Biomedical Research Center Baton Rouge Louisiana United States 70808

Sponsors and Collaborators

  • Pennington Biomedical Research Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eric Ravussin, Principal Investigator, Pennington Biomedical Research Center
ClinicalTrials.gov Identifier:
NCT01872533
Other Study ID Numbers:
  • PBRC 11009
First Posted:
Jun 7, 2013
Last Update Posted:
Dec 2, 2015
Last Verified:
Dec 1, 2015
Keywords provided by Eric Ravussin, Principal Investigator, Pennington Biomedical Research Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 2, 2015